IDEAYA Biosciences, Inc. (IDYA)
35.84
-0.22
(-0.61%)
USD |
NASDAQ |
Jan 16, 16:00
35.86
+0.02
(+0.06%)
After-Hours: 20:00
IDEAYA Biosciences Profit Margin (Quarterly): 57.37% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Pfizer Inc. | 21.32% |
| Sarepta Therapeutics, Inc. | -45.06% |
| Rezolute, Inc. | -- |
| Belite Bio, Inc. | -- |
| Kestra Medical Technologies Ltd. | -145.3% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -15.12% |
| Return on Assets | -14.12% |
| Return on Invested Capital | -14.79% |
| Gross Profit Margin (Quarterly) | 99.50% |
| Operating Margin (Quarterly) | 52.18% |
| Return on Net Operating Assets | -528.3% |